Weerts E M, Griffiths R R
Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA.
Behav Pharmacol. 1998 May;9(3):285-97.
Intravenous zolpidem self-injection, and the concurrent development of physical dependence under conditions of continuous drug availability, was characterized in three baboons. Previously, under similar conditions, 1.0 mg/kg midazolam maintained low, but stable, daily rates of self-injection (e.g. less than 20 injections/day) over 30 or more days and resulted in the development of physical dependence in baboons. In the current experiments, saline and zolpidem (1.0 mg/kg) were available for self-injection under a fixed-ratio (FR-30) schedule of lever-pull responses with a 5 min time-out after each injection. Saline maintained only low levels of responding (i.e. less than five injections per day). Zolpidem maintained an orderly spaced within-day pattern of injections and daily rates of self-injection were higher than saline (i.e. 10 or more injections per day). Daily rates of zolpidem self-injection were relatively stable in two baboons, and increased over time in the third baboon. Substitution of saline for zolpidem produced a rapid decrease in responding that remained low (i.e. less than five injections per day) in all three baboons. Chronic self-injection of zolpidem produced an increase in responding maintained by food pellet delivery and an increase in body weights. Administration of flumazenil (0.1-1.0 mg/kg, i.v.) after at least 35 days of zolpidem self-injection produced postures and behavioral signs typical of a classic flumazenil-precipitated benzodiazepine withdrawal syndrome. Substitution of saline after chronic zolpidem self-injection produced a time-limited spontaneous withdrawal syndrome. Behavioral signs and postures were similar to those observed during flumazenil-precipitated withdrawal and were most prominent during the first 8 days after zolpidem was discontinued. Therefore, like midazolam, zolpidem maintained self-injection and physical dependence developed under conditions of long-term continuous availability.
在三只狒狒身上研究了静脉注射唑吡坦的自我注射情况,以及在持续有药可得的条件下身体依赖性的同时发展情况。此前,在类似条件下,1.0毫克/千克的咪达唑仑在30天或更长时间内维持较低但稳定的每日自我注射率(例如每天少于20次注射),并导致狒狒产生身体依赖性。在当前实验中,生理盐水和唑吡坦(1.0毫克/千克)可在固定比率(FR - 30)的杠杆拉动反应时间表下进行自我注射,每次注射后有5分钟的超时。生理盐水仅维持低水平的反应(即每天少于5次注射)。唑吡坦维持了注射的有序日间模式,每日自我注射率高于生理盐水(即每天10次或更多次注射)。在两只狒狒中,唑吡坦的每日自我注射率相对稳定,而在第三只狒狒中随时间增加。用生理盐水替代唑吡坦会使反应迅速下降,在所有三只狒狒中都维持在低水平(即每天少于5次注射)。长期自我注射唑吡坦会使由食物颗粒递送维持的反应增加以及体重增加。在唑吡坦自我注射至少35天后静脉注射氟马西尼(0.1 - 1.0毫克/千克)会产生典型的氟马西尼诱发的苯二氮䓬戒断综合征的姿势和行为体征。长期唑吡坦自我注射后用生理盐水替代会产生限时性的自发戒断综合征。行为体征和姿势与氟马西尼诱发的戒断期间观察到的相似,在停用唑吡坦后的头8天最为明显。因此,与咪达唑仑一样,唑吡坦在长期持续可得的条件下维持自我注射并产生身体依赖性。